Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Gains from Sales and Divestitures (2017 - 2025)

Myomo filings provide 9 years of Gains from Sales and Divestitures readings, the most recent being $52821.0 for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 94.61% to $52821.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $52821.0, a 94.61% decrease, with the full-year FY2024 number at $1.0 million, up 195.87% from a year prior.
  • Gains from Sales and Divestitures hit $52821.0 in Q3 2025 for Myomo, down from $644149.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.0 million in Q4 2024 to a low of $10.0 in Q1 2021.
  • Median Gains from Sales and Divestitures over the past 5 years was $97158.0 (2022), compared with a mean of $245374.6.
  • Biggest five-year swings in Gains from Sales and Divestitures: crashed 99.85% in 2021 and later surged 485690.0% in 2022.
  • Myomo's Gains from Sales and Divestitures stood at $30.0 in 2021, then skyrocketed by 457673.33% to $137332.0 in 2022, then skyrocketed by 147.14% to $339409.0 in 2023, then soared by 195.87% to $1.0 million in 2024, then plummeted by 94.74% to $52821.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $52821.0 (Q3 2025), $644149.0 (Q2 2025), and $59031.0 (Q1 2025) per Business Quant data.